pyridinecarboxylicaciddimethylester,OxidizedNifedipineProperties:
| RelatedCategories | AnalyticalStandards,Analytical/Chromatography,EPStandards,EPStandardsN-O,Pharmacopeia&MetrologicalInstitutesStandards |
Description:
Biochem/physiolActions
CYP3A4nifedipinemetabolite.Nifedipine(parentcompound)isanantianginalandantihypertensiveagent.
Caution
PleasefindSDSprovidedbyEDQMhere.
.
Generaldescription
ThisproductisprovidedasdeliveredandspecifiedbytheissuingPharmacopoeia.Allinformationprovidedinsupportofthisproduct,includingSDSandanyproductinformationleafletshavebeendevelopedandissuedundertheAuthorityoftheIssuingPharmacopoeia.ForfurtherinformationandsupportpleasegotothewebsiteoftheissuingPharmacopoeia
.
OtherNotes
Salesrestrictionsmayapply.
Packaging
Unitquantity:25mg.Subjecttochange.TheproductisdeliveredassuppliedbytheissuingPharmacopoeia.Forthecurrentunitquantity,pleasevisittheEDQMreferencesubtancecatalogue
.
Safety:
Symbol

GHS05
Precautionarystatements
P280-P305+P351+P338+P310
RIDADR
NONHforallmodesoftransport